Logo image
Stereotactic radiosurgery alone or combined with embolization for brain arteriovenous malformations: A systematic review and meta-analysis
Journal article   Peer reviewed

Stereotactic radiosurgery alone or combined with embolization for brain arteriovenous malformations: A systematic review and meta-analysis

Dylan Russell, Travis Peck, Dale Ding, Ching-Jen Chen, Davis G. Taylor, Robert M. Starke, Cheng-Chia Lee and Jason P. Sheehan
Journal of Neurosurgery, Vol.128(5)
2018

Abstract

Combined Modality Therapy Embolization, Therapeutic Humans Intracranial Arteriovenous Malformations Radiosurgery adverse outcome Article artificial embolization brain arteriovenous malformation comparative study gamma knife radiosurgery human Medline meta analysis neuroimaging nuclear magnetic resonance imaging postoperative hemorrhage priority journal radiation response stereotactic radiosurgery systematic review brain arteriovenous malformation multimodality cancer therapy radiosurgery bleeding brain arteriovenous malformation cancer radiotherapy controlled study morbidity radiation injury Review
OBJECTIVE Embolization of brain arteriovenous malformations (AVMs) prior to stereotactic radiosurgery (SRS) has been reported to negatively affect obliteration rates. The goal of this systematic review and meta-analysis was to compare the outcomes of AVMs treated with embolization plus SRS (E+SRS group) and those of AVMs treated with SRS alone (SRS group). METHODS A literature review was performed using PubMed to identify studies with 10 or more AVM patients and obliteration data for both E+SRS and SRS groups. A meta-analysis was performed to compare obliteration rates between the E+SRS and SRS groups. RESULTS Twelve articles comprising 1716 patients were eligible for analysis. Among the patients with radiological follow-up data, complete obliteration was achieved in 48.4% of patients (330/681) in the E+SRS group compared with 62.7% of patients (613/978) in the SRS group. A meta-analysis of the pooled data revealed that the obliteration rate was significantly lower in the E+SRS group (OR 0.51, 95% CI 0.41-0.64, p < 0.00001). Symptomatic adverse radiation effects were observed in 6.6% (27/412 patients) and 11.1% (48/433 patients) of the E+SRS and SRS groups, respectively. The annual post-SRS hemorrhage rate was 2.0%-6.5% and 0%-2.0% for the E+SRS and SRS groups, respectively. The rates of permanent morbidity were 0%-6.7% and 0%-13.5% for the E+SRS and SRS groups, respectively. CONCLUSIONS Arteriovenous malformation treatment with combined embolization and SRS is associated with lower obliteration rates than those with SRS treatment alone. However, this comparison does not fully account for differences in the initial AVM characteristics in the E+SRS group as compared with those in the SRS group. Further studies are warranted to address these limitations. © AANS, 2018.

Metrics

5 Record Views

Details

Logo image